Elevance Health stock was falling ahead of the open Wednesday as the health insurer issued disappointing guidance. Shares of Elevance fell 7.7% to $298 in premarket trading Wednesday, while futures tracking the were up by 0.3%. The company reported adjusted quarterly earnings of $3.33 a share, as revenue rose to $49.3 billion from $45 billion a year ago.